Inhibition of JNK pathway after treatment with pharmacological inhibitors and siRNA at the indicated concentrations was confirmed by measuring JNK activity with phosphorylation of c-Jun at Ser63 and 73 residues in GCT cell lines COV434 and KGN (Fig. 1d and supplementary figure-1). Here, JUN is linked to granular cell tumor.